Insider Transactions in Q1 2022 at Concert Pharmaceuticals, Inc. (CNCE)
Insider Transaction List (Q1 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 15
2022
|
Roger D Tung Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
13,480
-1.36%
|
$40,440
$3.09 P/Share
|
Feb 14
2022
|
Marc A. Becker Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,762
-2.64%
|
$11,286
$3.08 P/Share
|
Feb 14
2022
|
James V Cassella Chief Development Officer |
SELL
Open market or private sale
|
Direct |
3,762
-1.94%
|
$11,286
$3.09 P/Share
|
Feb 14
2022
|
Jeffrey A Munsie Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,762
-3.52%
|
$11,286
$3.09 P/Share
|
Feb 14
2022
|
Nancy Stuart Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
6,049
-2.08%
|
$18,147
$3.08 P/Share
|
Jan 28
2022
|
Marc A. Becker Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
81,600
+22.46%
|
-
|
Jan 28
2022
|
James V Cassella Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
110,500
+23.75%
|
-
|
Jan 28
2022
|
Jeffrey A Munsie Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
63,700
+37.33%
|
-
|
Jan 28
2022
|
Nancy Stuart Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
120,400
+16.86%
|
-
|
Jan 28
2022
|
Roger D Tung Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
208,900
+9.75%
|
-
|
Jan 06
2022
|
Roger D Tung Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,240
-1.16%
|
$27,720
$3.09 P/Share
|
Jan 05
2022
|
Marc A. Becker Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,894
-4.52%
|
$8,682
$3.2 P/Share
|
Jan 05
2022
|
James V Cassella Chief Development Officer |
SELL
Open market or private sale
|
Direct |
2,894
-3.37%
|
$8,682
$3.19 P/Share
|
Jan 05
2022
|
Jeffrey A Munsie Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,894
-6.27%
|
$8,682
$3.2 P/Share
|
Jan 05
2022
|
Nancy Stuart Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,894
-1.67%
|
$8,682
$3.19 P/Share
|